A pairing appears on this page only when a trial gave both ingredients together and measured the result. Mushrooms has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Mushrooms contain ergosterol, which photoconverts to ergocalciferol (vitamin D2) under ultraviolet light in exactly the way skin 7-dehydrocholesterol converts to vitamin D3. UV-exposed mushrooms therefore carry meaningful D2, while mushrooms grown in the dark carry almost none. D2 and D3 both raise circulating 25-hydroxyvitamin D, though most head-to-head work finds D3 does so more efficiently per unit.
Mushroom-derived D2 and supplemental D3 are both hydroxylated in the liver to the 25-hydroxy form that gets measured. They contribute to the same pool but not at the same efficiency, with D3 generally raising and holding 25-hydroxyvitamin D better per microgram. A label that states total vitamin D without saying which form is hiding a real difference.
The structural polysaccharide of mushroom cell walls is beta-1,3/1,6-glucan, which is the same class of molecule sold as yeast beta-glucan and structurally distinct from the beta-1,3/1,4-glucan of oats. Whole mushroom and an isolated fungal beta-glucan therefore overlap in their main polysaccharide. The oat form behaves differently and should not be swapped in.
Human enzymes do not break down fungal beta-glucan or chitin, so those fractions arrive in the colon intact and become substrate for bacterial fermentation. A 2026 review positions edible mushrooms as an emerging prebiotic source acting through short-chain fatty acid production. The work is mechanistic and observational rather than a controlled test of the mushroom plus probiotic pair.
The prebiotic case for mushrooms rests on short-chain fatty acid production, butyrate included, by colonic bacteria fermenting the indigestible cell wall fraction. Supplemental butyrate supplies the end product directly and skips the fermentation. That means it also skips the shift in the bacterial population, so the two are not substitutes.
Mushrooms are frequently promoted as a plant-free B12 source, but fungi have no cobalamin biosynthesis pathway. Any B12 detected in mushroom material comes from surface bacteria or the growing substrate and is inconsistent and often present as inactive corrinoid analogues. Anyone relying on mushrooms for B12 needs a separate source.
Fungal mycelium takes up selenium from its substrate and incorporates it into selenoamino acids, which is why selenium-enriched mushrooms can be grown deliberately. The content therefore reflects the substrate rather than the species, and ordinary mushrooms are not a reliable selenium source. The same uptake behaviour applies to elements that are not wanted.
Cultivated mushrooms carry appreciable copper, and high-dose zinc supplementation competes with copper at the same intestinal transporter. Someone taking sustained high-dose zinc alongside a copper-poor diet is the person for whom this matters. The mushroom contribution is dietary and modest, not corrective.
Sustained high-dose zinc induces intestinal metallothionein, which traps copper in the enterocyte and lowers copper absorption. Dietary copper from mushrooms and other foods is what buffers this. The competition matters at supplemental zinc doses, not at food-level intakes.
Commercial mushroom products are usually blends rather than single species, and a randomised trial of one such blend reported measures on stress, fatigue and sleep. Because the blend was tested as a unit, the result cannot be attributed to any one species in it. The pairing is a formulation convention supported by one blend-level trial.
Reishi appears in most commercial mushroom blends alongside other species. The available randomised data is on blends as a whole, not on the individual contributions. Read any blend result as evidence about that specific blend and dose, not about reishi.
Cordyceps is routinely combined with other species in adaptogenic mushroom products. A randomised blend trial reported outcomes on stress, fatigue and sleep for the mixture. The design cannot separate what any single species contributed.
Turkey tail is used in blends chiefly for its polysaccharide fraction. Beta-glucan content per serving depends on the species, the part used and the extraction route rather than on how many species are present. Whether a mixed-species polysaccharide load does anything a single species does not has not been tested.
Nothing specific on file for Mushrooms. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 7 we read for Mushrooms. The full linked list is below.
2 sources behind our Mushrooms verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 431 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Mushrooms is, not how risky it is. A report is not proof Mushrooms caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.